Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma 2025 Ahead of print 2024 2023 2022 2021 2020 2019 2018 2016 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Neoplasma Vol.62, No.4, p.531-540, 2015 |
||
Title: A recombined fusion protein SP5.2/tTF induce thrombosis in tumor blood vessel | ||
Author: S. LV, M. YE, X. WANG, Z. LI, X. CHEN, X. DOU, Y. DAI, F. ZENG, L. LUO, C. WANG, K. LI, X. LUO, J. YAN, X. LI | ||
Abstract: Tumor vascular targeting is one of the most promising strategies in tumor therapy. Here we used E.coli to express a recombinant SP5.2/tTF fusion protein, which, as a tumor vascular targeting agent, consists of SP5.2 (a peptide selectively binding and targeting VEGFR-1 on tumor endothelial cells) and truncated tissue factor (tTF)and aimed to explore its anti-tumor activities. In tumor xenograft studies, SP5.2/tTF selectively targeted the tumor, induced thrombosis, and led to retardation and even regression of tumor growth (growth inhibition ratio = 70%, P< 0.05).
|
||
Keywords: truncated tissue factor, SP5.2, fusion protein, tumor vascular targeting, thrombosis, anti-tumor | ||
Published online: 18-May-2015 | ||
Year: 2015, Volume: 62, Issue: 4 | Page From: 531, Page To: 540 | |
doi:10.4149/neo_2015_064 |
||
|
![]() |
|